Article Details
Retrieved on: 2023-10-12 16:55:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The drug candidate, when combined with the Roche Holding AG (RHHBY) monoclonal antibodies Tecentriq and Avastin, showed clinical superiority in ...
Article found on: www.morningstar.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here